DarioHealth (NASDAQ:DRIO) executives highlighted record commercial momentum and continued cost reductions on the company’s fourth-quarter and year-end 2025 earnings call, while also addressing the rev ...
Good afternoon, everyone, and thank you for joining us today. 2025 was a year of exceptional execution, one that proved the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results